Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy
Clinical trial NCT02705820 · COMPLETED
Trial details
- NCT number
- NCT02705820
- Sponsor
- Bank of Cyprus Oncology Centre
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-25
- Primary completion
- 2023-05-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.